Study on the enhanced morphology around MRI after DEB-TACE in primary hepatocellular carcinoma
10.3760/cma.j.cn113884-20191211-00407
- VernacularTitle:原发性肝细胞癌DEB-TACE术后瘤周MRI强化边缘形态分析
- Author:
Donglin KUANG
1
;
Jianzhuang REN
;
Xuhua DUAN
;
Xuemei GAO
;
Xinwei HAN
;
Wenguang ZHANG
;
Pengfei CHEN
;
Nan ZHANG
;
Yang WANG
;
Shuguang JU
Author Information
1. 郑州大学第一附属医院放射介入科，郑州 450018
- From:
Chinese Journal of Hepatobiliary Surgery
2020;26(9):687-690
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the morphological feature and clinical significance of MRI around tumor after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE) of primary hepatocellular carcinoma.Methods:We reviewed and analyzed the data of hepatocellular carcinoma patients admitted from January 2017 to December 2018 in the Department of Radiological Intervention of the First Affiliated Hospital of Zhengzhou University. A total of 42 patients were enrolled, including 35 males and 7 females, aged (57.0±11.9) years. For the first time after operation, MRI enhancement showed peri-tumor margin enhancement as the starting point of follow-up. Follow-up and measure enhanced edge thickness, delayed enhancement, progression or remission data.Results:A total of 49 tumors and 84 peritumoral enhancement margins were included in 42 patients, with 30 sharp type , 40 rough type and 14 nodular type. The thickness of sharp type is less than that of rough type and nsodular type, and the differences were statistically significant (all P<0.05). The sharp type is the majority of the tumors with maximum diameter <5 cm, rough type and nodule type are the majority of tumors with maximum diameter ≥5 cm. Most of the sharp type are continuously enhanced, while the rough type and nodular type are not. Most sharp type relief (93.3%, 28/30), while rough type (80.0%, 32/40) and nodular type ( n=12) are mostly of deterioration, the differences are statistically significant (all P<0.05). Conclusion:Compared with the rough type and nodular type, the sharp type usually occurs in smaller tumors and more prone to local mitigation in the enhanced morphology around MRI after DEB-TACE in primary hepatocellular carcinoma.
